Page last updated: 2024-12-11

poloxin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

poloxin: a polo-box domain inhibitor; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9613592
CHEMBL ID3944542
MeSH IDM0570116

Synonyms (16)

Synonym
HY-12134
poloxin
AKOS000275766
CS-0668 ,
321688-88-4
(z)-2-isopropyl-5-methyl-4-(((2-methylbenzoyl)oxy)imino)cyclohexa-2,5-dienone
DTXSID30430634
CHEMBL3944542 ,
bdbm50206448
2-isopropyl-5-methyl-4-(((2-methylbenzoyl)oxy)imino)cyclohexa-2,5-dien-1-one
A923634
[(z)-(2-methyl-4-oxo-5-propan-2-ylcyclohexa-2,5-dien-1-ylidene)amino] 2-methylbenzoate
(z)-2-isopropyl-5-methyl-4-(((2-methylbenzoyl)oxy)imino)cyclohexa-2,5-dien-1-one
NCGC00378829-03
2-methyl-5-(1-methylethyl)-2,5-cyclohexadiene-1,4-dione 1-[o-(2-methylbenzoyl)oxime]
AS-77273

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Serine/threonine-protein kinase PLK1Homo sapiens (human)IC50 (µMol)17.10000.00010.77349.0000AID1331796; AID1874286
Serine/threonine-protein kinase PLK3Homo sapiens (human)IC50 (µMol)53.90000.00200.61037.2000AID1874288
Serine/threonine-protein kinase PLK2Homo sapiens (human)IC50 (µMol)18.70000.00350.24050.9572AID1874287
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Serine/threonine-protein kinase PLK1Homo sapiens (human)Kd151.40000.00010.57115.0000AID1331795; AID1628682; AID1628686
Serine/threonine-protein kinase PLK3Homo sapiens (human)Kd296.00000.00402.90568.5000AID1628684
Serine/threonine-protein kinase PLK2Homo sapiens (human)Kd87.30000.00081.80838.3000AID1628683
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (79)

Processvia Protein(s)Taxonomy
establishment of protein localizationSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic sister chromatid segregationSerine/threonine-protein kinase PLK1Homo sapiens (human)
G2/M transition of mitotic cell cycleSerine/threonine-protein kinase PLK1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IISerine/threonine-protein kinase PLK1Homo sapiens (human)
establishment of mitotic spindle orientationSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic cell cycleSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic cytokinesisSerine/threonine-protein kinase PLK1Homo sapiens (human)
microtubule bundle formationSerine/threonine-protein kinase PLK1Homo sapiens (human)
double-strand break repairSerine/threonine-protein kinase PLK1Homo sapiens (human)
protein phosphorylationSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic spindle organizationSerine/threonine-protein kinase PLK1Homo sapiens (human)
sister chromatid cohesionSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic chromosome condensationSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic nuclear membrane disassemblySerine/threonine-protein kinase PLK1Homo sapiens (human)
metaphase/anaphase transition of mitotic cell cycleSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic spindle assembly checkpoint signalingSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic G2 DNA damage checkpoint signalingSerine/threonine-protein kinase PLK1Homo sapiens (human)
centrosome cycleSerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of mitotic cell cycleSerine/threonine-protein kinase PLK1Homo sapiens (human)
positive regulation of peptidyl-threonine phosphorylationSerine/threonine-protein kinase PLK1Homo sapiens (human)
female meiosis chromosome segregationSerine/threonine-protein kinase PLK1Homo sapiens (human)
protein ubiquitinationSerine/threonine-protein kinase PLK1Homo sapiens (human)
peptidyl-serine phosphorylationSerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of mitotic metaphase/anaphase transitionSerine/threonine-protein kinase PLK1Homo sapiens (human)
protein destabilizationSerine/threonine-protein kinase PLK1Homo sapiens (human)
positive regulation of proteasomal ubiquitin-dependent protein catabolic processSerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of cytokinesisSerine/threonine-protein kinase PLK1Homo sapiens (human)
negative regulation of apoptotic processSerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of protein bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
homologous chromosome segregationSerine/threonine-protein kinase PLK1Homo sapiens (human)
negative regulation of cyclin-dependent protein serine/threonine kinase activitySerine/threonine-protein kinase PLK1Homo sapiens (human)
positive regulation of proteolysisSerine/threonine-protein kinase PLK1Homo sapiens (human)
Golgi inheritanceSerine/threonine-protein kinase PLK1Homo sapiens (human)
nuclear membrane disassemblySerine/threonine-protein kinase PLK1Homo sapiens (human)
positive regulation of ubiquitin-protein transferase activitySerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of cell cycleSerine/threonine-protein kinase PLK1Homo sapiens (human)
synaptonemal complex disassemblySerine/threonine-protein kinase PLK1Homo sapiens (human)
protein localization to chromatinSerine/threonine-protein kinase PLK1Homo sapiens (human)
protein localization to nuclear envelopeSerine/threonine-protein kinase PLK1Homo sapiens (human)
double-strand break repair via alternative nonhomologous end joiningSerine/threonine-protein kinase PLK1Homo sapiens (human)
positive regulation of protein localization to nucleusSerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of mitotic spindle assemblySerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of mitotic cell cycle phase transitionSerine/threonine-protein kinase PLK1Homo sapiens (human)
positive regulation of ubiquitin protein ligase activitySerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of protein localization to cell cortexSerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of anaphase-promoting complex-dependent catabolic processSerine/threonine-protein kinase PLK1Homo sapiens (human)
negative regulation of double-strand break repair via homologous recombinationSerine/threonine-protein kinase PLK1Homo sapiens (human)
G1/S transition of mitotic cell cycleSerine/threonine-protein kinase PLK3Homo sapiens (human)
G2/M transition of mitotic cell cycleSerine/threonine-protein kinase PLK3Homo sapiens (human)
negative regulation of transcription by RNA polymerase IISerine/threonine-protein kinase PLK3Homo sapiens (human)
response to reactive oxygen speciesSerine/threonine-protein kinase PLK3Homo sapiens (human)
protein phosphorylationSerine/threonine-protein kinase PLK3Homo sapiens (human)
apoptotic processSerine/threonine-protein kinase PLK3Homo sapiens (human)
response to osmotic stressSerine/threonine-protein kinase PLK3Homo sapiens (human)
DNA damage responseSerine/threonine-protein kinase PLK3Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestSerine/threonine-protein kinase PLK3Homo sapiens (human)
endomitotic cell cycleSerine/threonine-protein kinase PLK3Homo sapiens (human)
response to radiationSerine/threonine-protein kinase PLK3Homo sapiens (human)
cytoplasmic microtubule organizationSerine/threonine-protein kinase PLK3Homo sapiens (human)
regulation of cytokinesisSerine/threonine-protein kinase PLK3Homo sapiens (human)
negative regulation of apoptotic processSerine/threonine-protein kinase PLK3Homo sapiens (human)
mitotic G1/S transition checkpoint signalingSerine/threonine-protein kinase PLK3Homo sapiens (human)
regulation of cell divisionSerine/threonine-protein kinase PLK3Homo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionSerine/threonine-protein kinase PLK3Homo sapiens (human)
Golgi disassemblySerine/threonine-protein kinase PLK3Homo sapiens (human)
positive regulation of intracellular protein transportSerine/threonine-protein kinase PLK3Homo sapiens (human)
regulation of signal transduction by p53 class mediatorSerine/threonine-protein kinase PLK3Homo sapiens (human)
positive regulation of chaperone-mediated autophagySerine/threonine-protein kinase PLK3Homo sapiens (human)
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxiaSerine/threonine-protein kinase PLK3Homo sapiens (human)
mitotic spindle organizationSerine/threonine-protein kinase PLK3Homo sapiens (human)
G1/S transition of mitotic cell cycleSerine/threonine-protein kinase PLK2Homo sapiens (human)
negative regulation of inflammatory response to antigenic stimulusSerine/threonine-protein kinase PLK2Homo sapiens (human)
protein phosphorylationSerine/threonine-protein kinase PLK2Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestSerine/threonine-protein kinase PLK2Homo sapiens (human)
mitotic spindle organizationSerine/threonine-protein kinase PLK2Homo sapiens (human)
Ras protein signal transductionSerine/threonine-protein kinase PLK2Homo sapiens (human)
memorySerine/threonine-protein kinase PLK2Homo sapiens (human)
positive regulation of autophagySerine/threonine-protein kinase PLK2Homo sapiens (human)
negative regulation of angiogenesisSerine/threonine-protein kinase PLK2Homo sapiens (human)
peptidyl-serine phosphorylationSerine/threonine-protein kinase PLK2Homo sapiens (human)
Rap protein signal transductionSerine/threonine-protein kinase PLK2Homo sapiens (human)
negative regulation of apoptotic processSerine/threonine-protein kinase PLK2Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionSerine/threonine-protein kinase PLK2Homo sapiens (human)
positive regulation of protein catabolic processSerine/threonine-protein kinase PLK2Homo sapiens (human)
regulation of centriole replicationSerine/threonine-protein kinase PLK2Homo sapiens (human)
regulation of synaptic plasticitySerine/threonine-protein kinase PLK2Homo sapiens (human)
long-term synaptic potentiationSerine/threonine-protein kinase PLK2Homo sapiens (human)
long-term synaptic depressionSerine/threonine-protein kinase PLK2Homo sapiens (human)
negative regulation of apoptotic process in bone marrow cellSerine/threonine-protein kinase PLK2Homo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesisSerine/threonine-protein kinase PLK2Homo sapiens (human)
negative regulation of cellular senescenceSerine/threonine-protein kinase PLK2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (12)

Processvia Protein(s)Taxonomy
magnesium ion bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
protein kinase activitySerine/threonine-protein kinase PLK1Homo sapiens (human)
protein serine/threonine kinase activitySerine/threonine-protein kinase PLK1Homo sapiens (human)
protein bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
ATP bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
microtubule bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
anaphase-promoting complex bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
protein kinase bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
identical protein bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
protein serine kinase activitySerine/threonine-protein kinase PLK1Homo sapiens (human)
p53 bindingSerine/threonine-protein kinase PLK3Homo sapiens (human)
protein serine/threonine kinase activitySerine/threonine-protein kinase PLK3Homo sapiens (human)
protein bindingSerine/threonine-protein kinase PLK3Homo sapiens (human)
ATP bindingSerine/threonine-protein kinase PLK3Homo sapiens (human)
protein serine kinase activitySerine/threonine-protein kinase PLK3Homo sapiens (human)
protein serine/threonine kinase activitySerine/threonine-protein kinase PLK2Homo sapiens (human)
protein bindingSerine/threonine-protein kinase PLK2Homo sapiens (human)
ATP bindingSerine/threonine-protein kinase PLK2Homo sapiens (human)
ATP-dependent protein bindingSerine/threonine-protein kinase PLK2Homo sapiens (human)
protein serine kinase activitySerine/threonine-protein kinase PLK2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (22)

Processvia Protein(s)Taxonomy
spindle microtubuleSerine/threonine-protein kinase PLK1Homo sapiens (human)
kinetochoreSerine/threonine-protein kinase PLK1Homo sapiens (human)
synaptonemal complexSerine/threonine-protein kinase PLK1Homo sapiens (human)
spindle poleSerine/threonine-protein kinase PLK1Homo sapiens (human)
nucleusSerine/threonine-protein kinase PLK1Homo sapiens (human)
nucleoplasmSerine/threonine-protein kinase PLK1Homo sapiens (human)
centrosomeSerine/threonine-protein kinase PLK1Homo sapiens (human)
centrioleSerine/threonine-protein kinase PLK1Homo sapiens (human)
spindleSerine/threonine-protein kinase PLK1Homo sapiens (human)
cytosolSerine/threonine-protein kinase PLK1Homo sapiens (human)
microtubule cytoskeletonSerine/threonine-protein kinase PLK1Homo sapiens (human)
midbodySerine/threonine-protein kinase PLK1Homo sapiens (human)
centriolar satelliteSerine/threonine-protein kinase PLK1Homo sapiens (human)
spindle midzoneSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic spindle poleSerine/threonine-protein kinase PLK1Homo sapiens (human)
chromatinSerine/threonine-protein kinase PLK1Homo sapiens (human)
outer kinetochoreSerine/threonine-protein kinase PLK1Homo sapiens (human)
nucleusSerine/threonine-protein kinase PLK1Homo sapiens (human)
centrosomeSerine/threonine-protein kinase PLK1Homo sapiens (human)
cytoplasmSerine/threonine-protein kinase PLK1Homo sapiens (human)
spindle poleSerine/threonine-protein kinase PLK1Homo sapiens (human)
kinetochoreSerine/threonine-protein kinase PLK1Homo sapiens (human)
nucleusSerine/threonine-protein kinase PLK3Homo sapiens (human)
nucleoplasmSerine/threonine-protein kinase PLK3Homo sapiens (human)
nucleolusSerine/threonine-protein kinase PLK3Homo sapiens (human)
cytoplasmSerine/threonine-protein kinase PLK3Homo sapiens (human)
Golgi stackSerine/threonine-protein kinase PLK3Homo sapiens (human)
centrosomeSerine/threonine-protein kinase PLK3Homo sapiens (human)
dendriteSerine/threonine-protein kinase PLK3Homo sapiens (human)
neuronal cell bodySerine/threonine-protein kinase PLK3Homo sapiens (human)
kinetochoreSerine/threonine-protein kinase PLK3Homo sapiens (human)
centrosomeSerine/threonine-protein kinase PLK3Homo sapiens (human)
nucleusSerine/threonine-protein kinase PLK3Homo sapiens (human)
spindle poleSerine/threonine-protein kinase PLK3Homo sapiens (human)
cytoplasmSerine/threonine-protein kinase PLK3Homo sapiens (human)
cytoplasmSerine/threonine-protein kinase PLK2Homo sapiens (human)
centrosomeSerine/threonine-protein kinase PLK2Homo sapiens (human)
centrioleSerine/threonine-protein kinase PLK2Homo sapiens (human)
cytosolSerine/threonine-protein kinase PLK2Homo sapiens (human)
dendriteSerine/threonine-protein kinase PLK2Homo sapiens (human)
chromatinSerine/threonine-protein kinase PLK2Homo sapiens (human)
spindle poleSerine/threonine-protein kinase PLK2Homo sapiens (human)
centrioleSerine/threonine-protein kinase PLK2Homo sapiens (human)
centrosomeSerine/threonine-protein kinase PLK2Homo sapiens (human)
cytoplasmSerine/threonine-protein kinase PLK2Homo sapiens (human)
kinetochoreSerine/threonine-protein kinase PLK2Homo sapiens (human)
nucleusSerine/threonine-protein kinase PLK2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (16)

Assay IDTitleYearJournalArticle
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID1628684Binding affinity to GST-tagged PLK3 PBD (335 to 646 residues) (unknown origin) by NT-647 dye-based microscale thermophoresis analysis2016Journal of medicinal chemistry, Aug-11, Volume: 59, Issue:15
Discovery of Novel Polo-Like Kinase 1 Polo-Box Domain Inhibitors to Induce Mitotic Arrest in Tumor Cells.
AID1331795Binding affinity to NT-647 labeled PLK1 polo-box domain (unknown origin) expressed in Escherichia coli Rosetta (DE3) by microscale thermophoresis based fluorescence assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Identification of acylthiourea derivatives as potent Plk1 PBD inhibitors.
AID1628701Induction of mitotic arrest in human HeLa cells assessed as 4N DNA cells at 100 uM after 24 hrs by propidium iodide staining-based FACS analysis relative to control2016Journal of medicinal chemistry, Aug-11, Volume: 59, Issue:15
Discovery of Novel Polo-Like Kinase 1 Polo-Box Domain Inhibitors to Induce Mitotic Arrest in Tumor Cells.
AID1628680Binding affinity to GST-tagged PLK1 PBD H538A mutant (unknown origin) by NT-647 dye-based microscale thermophoresis analysis2016Journal of medicinal chemistry, Aug-11, Volume: 59, Issue:15
Discovery of Novel Polo-Like Kinase 1 Polo-Box Domain Inhibitors to Induce Mitotic Arrest in Tumor Cells.
AID1628682Binding affinity to GST-tagged PLK1 PBD (327 to 603 residues) (unknown origin) by NT-647 dye-based microscale thermophoresis analysis2016Journal of medicinal chemistry, Aug-11, Volume: 59, Issue:15
Discovery of Novel Polo-Like Kinase 1 Polo-Box Domain Inhibitors to Induce Mitotic Arrest in Tumor Cells.
AID1874287Inhibition of 5-carboxyfluorescein-GPMQTSpTPKNG-OH peptide binding to C-terminal 6His-tagged human PLK2 (355 to 685 residues) PBD expressed in Rosetta BL21 (DE3) cells preincubated for 1 hrs with compound followed by peptide addition and measured immediat2022Journal of medicinal chemistry, 08-11, Volume: 65, Issue:15
Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential.
AID1874288Inhibition of 5-carboxyfluorescein-GPLATSpTPKNG-OH peptide binding to N-terminal MBP-tagged human PLK3 (335 to 646 residues) PBD expressed in Rosetta BL21 (DE3) cells preincubated for 1 hrs with compound followed by peptide addition and measured immediate2022Journal of medicinal chemistry, 08-11, Volume: 65, Issue:15
Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential.
AID1628686Binding affinity to GST-tagged PLK1 PBD W414A mutant (unknown origin) by NT-647 dye-based microscale thermophoresis analysis2016Journal of medicinal chemistry, Aug-11, Volume: 59, Issue:15
Discovery of Novel Polo-Like Kinase 1 Polo-Box Domain Inhibitors to Induce Mitotic Arrest in Tumor Cells.
AID1331796Inhibition of 5-FAM-DPPLHSpTAI-OH binding to PLK1 polo-box domain (unknown origin) expressed in Escherichia coli Rosetta (DE3) after 1 hr by fluorescence polarization assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Identification of acylthiourea derivatives as potent Plk1 PBD inhibitors.
AID1874286Inhibition of 5-carboxyfluoresceinGPMQSpTPLNG-OH peptide binding to human PLK1 (326 to 603 residues) PBD expressed in Rosetta BL21 (DE3) cells preincubated for 1 hrs with compound followed by peptide addition and measured immediately by fluorescence polar2022Journal of medicinal chemistry, 08-11, Volume: 65, Issue:15
Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential.
AID1628685Binding affinity to GST-tagged PLK1 PBD K540A mutant (unknown origin) by NT-647 dye-based microscale thermophoresis analysis2016Journal of medicinal chemistry, Aug-11, Volume: 59, Issue:15
Discovery of Novel Polo-Like Kinase 1 Polo-Box Domain Inhibitors to Induce Mitotic Arrest in Tumor Cells.
AID1628683Binding affinity to GST-tagged PLK2 PBD (355 to 685 residues) (unknown origin) by NT-647 dye-based microscale thermophoresis analysis2016Journal of medicinal chemistry, Aug-11, Volume: 59, Issue:15
Discovery of Novel Polo-Like Kinase 1 Polo-Box Domain Inhibitors to Induce Mitotic Arrest in Tumor Cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (6.25)29.6817
2010's13 (81.25)24.3611
2020's2 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.87 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.91 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]